Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis

Acta Otolaryngol. 2003 Apr;123(3):377-82. doi: 10.1080/00016480310001376.

Abstract

Objective: To investigate differences in cell proliferation, cell cycle arrest and apoptosis between cholesteatoma and control skin.

Material and methods: Immunohistochemical sections of 15 cholesteatoma and 15 paired control retro-auricular skin samples were examined for Ki-67, p53, p21 and active caspase 3, using image analysis, as well as for DNA fragmentation.

Results: The retro-auricular skin samples contained 5.7% +/- 3.6%, Ki-67-positive cells and showed a normal expression pattern. In the cholesteatoma epithelium 11.7% +/- 9.5% of the cells were Ki-67-positive and these cells were dominantly expressed in the basal and parabasal cell layers. Retro-auricular skin contained 5.8% +/- 5.4% p53-positive cells and 1.0% +/- 0.9%, p21-positive cells. In the cholesteatoma epithelium 17.8% +/- 12.3% of the cells were p53-positive and 14.3% +/- 11.6% were p21-positive The expression of Ki-67, p53 and p21 differed significantly between the two groups (p < 0.05). In the cholesteatoma epithelium a positive correlation was found between p53 and p21 expression (p = 0.016). Active caspase 3 positivity and DNA fragmentation were rarely seen in the cholesteatoma epithelium.

Conclusion: Our results indicate that increased cell proliferation in cholesteatoma epithelium is accompanied by an increase in p53 and p21 protein levels, whilst apoptosis is minimal.

MeSH terms

  • Apoptosis
  • Case-Control Studies
  • Cholesteatoma, Middle Ear / metabolism*
  • Cholesteatoma, Middle Ear / pathology
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / metabolism*
  • Epithelial Cells / metabolism*
  • Epithelial Cells / pathology
  • Humans
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Ki-67 Antigen / metabolism*
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Ki-67 Antigen
  • Tumor Suppressor Protein p53